| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |